Table 1.
Risk of bias assessment for the reference standard in Cochrane reviews of diagnostic tests for COVID-19
Author [Reference] | Test(s) | No. of studies | No. of participants* | No. (%) of studies at high risk of bias | No. (%) of studies at unclear risk of bias | No. (%) of studies at low risk of bias |
---|---|---|---|---|---|---|
Struyf et al. [11] | Signs and symptoms | 44 | 26,884 | 3 (7) | 8 (18) | 33 (75) |
Stegeman et al. [12] | Routine laboratory tests | 21 | 70,711 | 14 (67) | 5 (24) | 2 (10) |
Dinnes et al. [13] | Rapid, point-of-care antigen and molecular-based tests | 78 | 24,087 | 66 (85) | 6 (8) | 6 (8) |
Deeks et al. [14] | Antibody tests | 54 | 15,976 | 17 (31) | 24 (24) | 13 (24) |
Islam et al. [15] | Thoracic imaging tests | 51 | 19,775 | 20 (39) | 20 (39) | 11 (22) |
TOTAL | - | 248 | 157,433 | 120 (48) | 63 (25) | 65 (26) |
* or samples
Table updated on May 20th, 2021